Background: Concerns have been raised that parents may be reluctant to have their
daughters receive the human papillomavirus (HPV) vaccine, because of a belief that doing …

Background: Although already approved for use in males in some jurisdictions, there is little
information about parental attitudes toward having their sons receive the human …

Background: In October 2009, a quadrivalent vaccine for human papillomavirus (HPV) was
licensed in the United States for males aged 9 to 26 years. The attitudes and beliefs of …

Background 1) To identify socio-demographic factors associated with parental “no-intent” for
their 13–17 year old unvaccinated daughter to receive the human papillomavirus (HPV) …

OBJECTIVE: To explore low-income minority parents' attitudes, intentions, and actions with
regard to human papillomavirus (HPV) vaccination for their daughters. STUDY DESIGN …

PURPOSE: To examine the relationships of demographics, parenting, and vaccine attitudes
with the acceptance of the human papillomavirus (HPV) vaccine or to the intent to vaccinate …

The goal of the study was to examine the reasons given by parents who accepted or refused
the HPV vaccine for their daughters in the context of a free provincial school-based …

This study examined parental responses to the quadrivalent human papillomavirus (HPV)
vaccine approximately 2 years post-licensure. Correlates of vaccine uptake included …

CONTEXT: Human papillomavirus (HPV) vaccine, licensed for use in 9‐–26‐year‐olds, is
most effective when given before sexual activity begins. HPV causes genital warts, is …

PURPOSE: Human papillomavirus (HPV) is the most common sexually transmitted infection
in the United States. Adolescent and young adults aged 15–24 were estimated to account …